Novo Integrated Sciences / Novo Healthnet Acquire Acenzia Inc.

ANI Pharmaceuticals Acquires Novitium Pharma for $163.5M

March 9, 2021

Pharmaceuticals

ANI Pharmaceuticals completed the acquisition of Novitium Pharma for $163.5 million (including $89.5M cash and $74M equity, plus up to $46.5M in contingent earn-outs), adding a U.S.-based R&D engine and CDMO manufacturing capacity. The deal, financed with a new $300M Term Loan B, a $40M revolver and a $25M PIPE investment from Ampersand Capital Partners, is expected to be immediately accretive and expand ANI's generics, contract manufacturing and 505(b)(2) capabilities.

Novo Holdings Acquires Altasciences from Audax Private Equity

February 22, 2021

Healthcare Services

Novo Holdings has agreed to acquire Altasciences, a Laval, Canada–headquartered contract research and CDMO services provider, from Audax Private Equity. Altasciences— which operates six facilities across the U.S. and Canada and employs over 1,300 people—will remain led by CEO Chris Perkin and is expected to continue expanding domestically and internationally under Novo Holdings' ownership.

Novo Integrated Sciences Acquires Clinical Consultants International LLC

March 23, 2022

Healthcare Services

Novo Integrated Sciences (NASDAQ: NVOS) has acquired Clinical Consultants International LLC (CCI) in an all-stock transaction, completing the purchase in April 2022. CCI, a Boca Raton–based global healthcare consulting firm led by Dr. Joseph M. Chalil, will see Dr. Chalil appointed Chief Medical Officer of Novo and President of Novomerica Health Group to expand Novo's healthcare capabilities and market entry services.

Cardinal Health Acquires Integrated Oncology Network for $1.115B

September 20, 2024

Healthcare Services

Cardinal Health has entered into a definitive agreement to acquire Integrated Oncology Network (ION) for $1.115 billion in cash. The acquisition adds more than 50 community-based practice sites and 100+ providers to Cardinal's Navista oncology practice alliance and expands the company's specialty oncology capabilities and practice management offerings.

Avant Technologies Proposes Acquisition of Ainnova Tech to Consolidate Vision AI JV

May 13, 2025

Healthcare Services

Avant Technologies has entered formal negotiations to acquire its joint-venture partner Ainnova Tech (operating through Ai-nova Acquisition Corp.), aiming to merge the businesses ahead of an FDA pre-submission meeting. The deal is intended to streamline regulatory coordination, speed clinical development and support U.S. market entry for the Vision AI clinical screening platform currently piloted across Latin America.

ADQ Acquires Acino from Avista Capital and Nordic Capital

September 16, 2021

Pharmaceuticals

Abu Dhabi holding company ADQ has agreed to acquire Acino, a Swiss pharmaceutical company headquartered in Zurich, from private equity owners Avista Capital Partners and Nordic Capital. The transaction supports ADQ's strategy to build a regional pharmaceuticals and healthcare platform, expanding capabilities in manufacturing, commercialization and distribution across emerging markets.